A citation-based method for searching scientific literature

Petar M Seferović, Walter J Paulus. Eur Heart J 2015
Times Cited: 285







List of co-cited articles
1060 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
25

Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
Guanghong Jia, Michael A Hill, James R Sowers. Circ Res 2018
572
25

New type of cardiomyopathy associated with diabetic glomerulosclerosis.
S Rubler, J Dlugash, Y Z Yuceoglu, T Kumral, A W Branwood, A Grishman. Am J Cardiol 1972
20

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
Michael R MacDonald, Mark C Petrie, Fumi Varyani, Jan Ostergren, Eric L Michelson, James B Young, Scott D Solomon, Christopher B Granger, Karl Swedberg, Salim Yusuf,[...]. Eur Heart J 2008
395
20

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
20

Role of diabetes in congestive heart failure: the Framingham study.
W B Kannel, M Hjortland, W P Castelli. Am J Cardiol 1974
19

Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology.
Petar M Seferović, Mark C Petrie, Gerasimos S Filippatos, Stefan D Anker, Giuseppe Rosano, Johann Bauersachs, Walter J Paulus, Michel Komajda, Francesco Cosentino, Rudolf A de Boer,[...]. Eur J Heart Fail 2018
254
19


Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.
Guanghong Jia, Vincent G DeMarco, James R Sowers. Nat Rev Endocrinol 2016
348
17

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
16

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
Francesco Cosentino, Peter J Grant, Victor Aboyans, Clifford J Bailey, Antonio Ceriello, Victoria Delgado, Massimo Federici, Gerasimos Filippatos, Diederick E Grobbee, Tina Birgitte Hansen,[...]. Eur Heart J 2020
16

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
16

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur Heart J 2016
13

Molecular mechanisms of diabetic cardiomyopathy.
Heiko Bugger, E Dale Abel. Diabetologia 2014
479
12

Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).
Søren L Kristensen, Ulrik M Mogensen, Pardeep S Jhund, Mark C Petrie, David Preiss, Sithu Win, Lars Køber, Robert S McKelvie, Michael R Zile, Inder S Anand,[...]. Circulation 2017
90
13

Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension.
Loek van Heerebeek, Nazha Hamdani, M Louis Handoko, Ines Falcao-Pires, René J Musters, Koba Kupreishvili, Alexander J J Ijsselmuiden, Casper G Schalkwijk, Jean G F Bronzwaer, Michaela Diamant,[...]. Circulation 2008
474
12

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
11

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
11

Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors.
G A Nichols, T A Hillier, J R Erbey, J B Brown. Diabetes Care 2001
376
10

Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
Maximilian E Hölscher, Christoph Bode, Heiko Bugger. Int J Mol Sci 2016
81
12

Heart Failure in Type 2 Diabetes Mellitus.
Helena C Kenny, E Dale Abel. Circ Res 2019
190
10

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann,[...]. N Engl J Med 2020
10

Diabetic cardiomyopathy revisited.
Sihem Boudina, E Dale Abel. Circulation 2007
10

Oxidative stress and diabetic complications.
Ferdinando Giacco, Michael Brownlee. Circ Res 2010
9

Impact of diabetes on cardiac structure and function: the strong heart study.
R B Devereux, M J Roman, M Paranicas, M J O'Grady, E T Lee, T K Welty, R R Fabsitz, D Robbins, E R Rhoades, B V Howard. Circulation 2000
641
9

Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.
Zhi You Fang, Johannes B Prins, Thomas H Marwick. Endocr Rev 2004
661
9

The incidence of congestive heart failure in type 2 diabetes: an update.
Gregory A Nichols, Christina M Gullion, Carol E Koro, Sara A Ephross, Jonathan B Brown. Diabetes Care 2004
492
9

Heart failure prevalence, incidence, and mortality in the elderly with diabetes.
Alain G Bertoni, W Gregory Hundley, Mark W Massing, Denise E Bonds, Gregory L Burke, David C Goff. Diabetes Care 2004
362
9


Diabetic cardiomyopathy--fact or fiction?
B Maisch, P Alter, S Pankuweit. Herz 2011
113
9

Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
Jonathan Yap, Wan Ting Tay, Tiew-Hwa Katherine Teng, Inder Anand, A Mark Richards, Lieng Hsi Ling, Michael R MacDonald, Chanchal Chandramouli, Jasper Tromp, Bambang B Siswanto,[...]. J Am Heart Assoc 2019
35
25

Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy.
Thomas H Marwick, Rebecca Ritchie, Jonathan E Shaw, David Kaye. J Am Coll Cardiol 2018
137
9

Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus.
John K Boyer, Srihari Thanigaraj, Kenneth B Schechtman, Julio E Pérez. Am J Cardiol 2004
325
8

Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients.
Dean T Eurich, Daniala L Weir, Sumit R Majumdar, Ross T Tsuyuki, Jeffrey A Johnson, Lisa Tjosvold, Saskia E Vanderloo, Finlay A McAlister. Circ Heart Fail 2013
205
8

Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
Matthew A Cavender, Ph Gabriel Steg, Sidney C Smith, Kim Eagle, E Magnus Ohman, Shinya Goto, Julia Kuder, Kyungah Im, Peter W F Wilson, Deepak L Bhatt. Circulation 2015
264
8

Myocardial fatty acid metabolism in health and disease.
Gary D Lopaschuk, John R Ussher, Clifford D L Folmes, Jagdip S Jaswal, William C Stanley. Physiol Rev 2010
8

Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study.
Brian R Lindman, Victor G Dávila-Román, Douglas L Mann, Steven McNulty, Marc J Semigran, Gregory D Lewis, Lisa de las Fuentes, Susan M Joseph, Justin Vader, Adrian F Hernandez,[...]. J Am Coll Cardiol 2014
120
8

Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy.
Isabella Evangelista, Ranuccio Nuti, Tommaso Picchioni, Francesco Dotta, Alberto Palazzuoli. Int J Mol Sci 2019
47
17

Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.
Guanghong Jia, Adam Whaley-Connell, James R Sowers. Diabetologia 2018
259
8

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.
Deepak L Bhatt, Michael Szarek, P Gabriel Steg, Christopher P Cannon, Lawrence A Leiter, Darren K McGuire, Julia B Lewis, Matthew C Riddle, Adriaan A Voors, Marco Metra,[...]. N Engl J Med 2021
418
8

Glycemic control and heart failure among adult patients with diabetes.
C Iribarren, A J Karter, A S Go, A Ferrara, J Y Liu, S Sidney, J V Selby. Circulation 2001
479
7

Diagnostic approaches for diabetic cardiomyopathy.
A Lorenzo-Almorós, J Tuñón, M Orejas, M Cortés, J Egido, Ó Lorenzo. Cardiovasc Diabetol 2017
98
7


Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.
Eri T Kato, Michael G Silverman, Ofri Mosenzon, Thomas A Zelniker, Avivit Cahn, Remo H M Furtado, Julia Kuder, Sabina A Murphy, Deepak L Bhatt, Lawrence A Leiter,[...]. Circulation 2019
272
7

The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota.
Sanjay Dandamudi, Joshua Slusser, Douglas W Mahoney, Margaret M Redfield, Richard J Rodeheffer, Horng H Chen. J Card Fail 2014
78
8

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
7

Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology.
Christoph Maack, Michael Lehrke, Johannes Backs, Frank R Heinzel, Jean-Sebastien Hulot, Nikolaus Marx, Walter J Paulus, Patrick Rossignol, Heinrich Taegtmeyer, Johann Bauersachs,[...]. Eur Heart J 2018
114
7


Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
7

The Failing Heart Relies on Ketone Bodies as a Fuel.
Gregory Aubert, Ola J Martin, Julie L Horton, Ling Lai, Rick B Vega, Teresa C Leone, Timothy Koves, Stephen J Gardell, Marcus Krüger, Charles L Hoppel,[...]. Circulation 2016
338
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.